Abstract

ABSTRACTRenal fibrosis is a serious clinical problem resulting in the greatest need for renal replacement therapy. No adequate preventive or curative therapy is available that could be clinically used to target renal fibrosis specifically. The search for new efficacious treatment strategies is therefore warranted. Although in vitro models using homogeneous cell populations have contributed to the understanding of the pathogenetic mechanisms involved in renal fibrosis, these models poorly mimic the complex in vivo milieu. Therefore, we here evaluated a precision-cut kidney slice (PCKS) model as a new, multicellular ex vivo model to study the development of fibrosis and its prevention using anti-fibrotic compounds. Precision-cut slices (200-300 μm thickness) were prepared from healthy C57BL/6 mouse kidneys using a Krumdieck tissue slicer. To induce changes mimicking the fibrotic process, slices were incubated with TGFβ1 (5 ng/ml) for 48 h in the presence or absence of the anti-fibrotic cytokine IFNγ (1 µg/ml) or an IFNγ conjugate targeted to PDGFRβ (PPB-PEG-IFNγ). Following culture, tissue viability (ATP-content) and expression of α-SMA, fibronectin, collagen I and collagen III were determined using real-time PCR and immunohistochemistry. Slices remained viable up to 72 h of incubation, and no significant effects of TGFβ1 and IFNγ on viability were observed. TGFβ1 markedly increased α-SMA, fibronectin and collagen I mRNA and protein expression levels. IFNγ and PPB-PEG-IFNγ significantly reduced TGFβ1-induced fibronectin, collagen I and collagen III mRNA expression, which was confirmed by immunohistochemistry. The PKCS model is a novel tool to test the pathophysiology of fibrosis and to screen the efficacy of anti-fibrotic drugs ex vivo in a multicellular and pro-fibrotic milieu. A major advantage of the slice model is that it can be used not only for animal but also for (fibrotic) human kidney tissue.

Highlights

  • In this study, precision-cut kidney slice (PCKS) were prepared from healthy C57BL/6 mouse kidneys using a Krumdieck tissue slicer

  • The present study reveals the applicability of PCKS as: (1) an ex vivo model to study renal fibrogenesis, and (2) to test anti-fibrotic effects of IFNγ and targeted IFNγ aiming at reducing renal fibrosis

  • The results demonstrate that incubation of mPCKS with TGFβ1 resulted in upregulation of fibronectin, collagen I and α-SMA expression, which indicates that mPCKS represent an ideal model to study the onset of early fibrosis

Read more

Summary

Introduction

Renal fibrosis is a major contributor to the development of chronic kidney disease (CKD) and is characterized by accumulation of. CKD culminates in end-stage renal disease (ESRD), resulting in significant morbidity and mortality, for which the only available therapy is dialysis or renal transplantation (Levey et al, 2007). Renal research is performed in in vitro cell culture systems or small rodent models as well as on human renal biopsies or explants (Westra et al, 2013). Use of human tissue biopsies is by definition descriptive in nature and prohibits functional studies

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call